Price movement over the last 24 hours
Alcon AG vs Global X Lithium & Battery Tech ETF — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while Global X Lithium & Battery Tech ETF trades at $72.7. The key difference: Alcon AG pays a 0.54% dividend while Global X Lithium & Battery Tech ETF pays none, and Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, Alcon AG nearer its low. Which is the better fit depends on your goals.
| ALC | LIT | |
|---|---|---|
Market Cap | $32.69B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $92.22 | $91.62 |
52-Week Low | $62.02 | $39.41 |
Enterprise Value | $36.28B | — |
Dividend Yield | 0.54% | — |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
LIT (Global X Lithium & Battery Tech ETF) trades at $76.17, down 0.47% with a bearish technical outlook. The ETF faces selling pressure from moving averages but maintains neutral oscillator readings. Recent news highlights strong momentum driven by energy storage, semiconductors, and EV demand, with the fund returning 125% from last year's lows according to 24/7 Wall Street on June 7, 2026. Key financial ratios remain undisclosed in current data.
Outlook remains mixed with technical weakness offset by strong sector catalysts. Investment opportunity lies in exposure to lithium and battery technology growth, particularly from EV and AI demand. Risks include reliance on Chinese supply chains, regulatory changes, and commodity price volatility. The upcoming dividend of $0.32 per share scheduled for July 2026 provides income potential.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →